CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Bayer AG - BAYN CFD

53.45
1.66%
0.15
Low: 53.45
High: 54.4
Market Trading Hours* (UTC) Opens on Wednesday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.15
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.019974 %
Charges from borrowed part ($-0.80)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.019974%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.002248 %
Charges from borrowed part ($-0.09)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.002248%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 20%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Bayer AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 54.35
Open* 54.2
1-Year Change* -18.5%
Day's Range* 53.45 - 54.4
52 wk Range 46.70-67.49
Average Volume (10 days) 1.86M
Average Volume (3 months) 45.82M
Market Cap 52.48B
P/E Ratio 17.28
Shares Outstanding 982.42M
Revenue 50.49B
EPS 3.09
Dividend (Yield %) 4.4927
Beta 1.22
Next Earnings Date Aug 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 29, 2023 54.35 -0.05 -0.09% 54.40 54.90 54.25
May 26, 2023 54.25 0.90 1.69% 53.35 54.50 53.20
May 25, 2023 53.30 -0.40 -0.74% 53.70 53.70 51.95
May 24, 2023 53.85 0.90 1.70% 52.95 54.15 52.95
May 23, 2023 54.00 0.30 0.56% 53.70 54.10 53.35
May 22, 2023 54.00 -0.50 -0.92% 54.50 54.65 53.95
May 19, 2023 54.55 1.60 3.02% 52.95 54.70 52.95
May 18, 2023 54.10 0.55 1.03% 53.55 54.50 53.55
May 17, 2023 53.75 0.25 0.47% 53.50 53.80 52.95
May 16, 2023 53.70 0.50 0.94% 53.20 54.15 53.10
May 15, 2023 53.20 -0.85 -1.57% 54.05 54.20 52.10
May 12, 2023 53.80 0.40 0.75% 53.40 54.60 53.40
May 11, 2023 54.05 -2.30 -4.08% 56.35 56.40 53.60
May 10, 2023 58.15 -0.20 -0.34% 58.35 58.55 58.00
May 9, 2023 58.15 -0.05 -0.09% 58.20 58.30 57.85
May 8, 2023 58.25 -0.20 -0.34% 58.45 58.50 57.95
May 5, 2023 58.45 0.10 0.17% 58.35 58.50 57.55
May 4, 2023 58.00 0.85 1.49% 57.15 58.20 57.15
May 3, 2023 57.10 -0.05 -0.09% 57.15 57.60 56.60
May 2, 2023 57.05 -0.45 -0.78% 57.50 58.00 57.00

Bayer AG Events

Time (UTC) Country Event
Tuesday, June 20, 2023

Time (UTC)

17:00

Country

DE

Event

Bayer AG Crop Science Innovation Summit
Bayer AG Crop Science Innovation Summit

Forecast

-

Previous

-
Wednesday, June 28, 2023

Time (UTC)

07:00

Country

DE

Event

Bayer AG Pharmaceuticals R&D Event
Bayer AG Pharmaceuticals R&D Event

Forecast

-

Previous

-
Tuesday, August 8, 2023

Time (UTC)

05:30

Country

DE

Event

Q2 2023 Bayer AG Earnings Release
Q2 2023 Bayer AG Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 50739 44081 41400 43545 36742
Revenue 50739 44081 41400 43545 36742
Cost of Revenue, Total 19871 16816 19138 17613 15381
Gross Profit 30868 27265 22262 25932 21361
Total Operating Expense 43727 40728 57569 39383 33288
Selling/General/Admin. Expenses, Total 16919 15370 15980 16156 14881
Research & Development 6572 5412 7126 5301 5105
Interest Expense (Income) - Net Operating 499 42 -54 183 -4
Unusual Expense (Income) 468 3484 15345 315 -3600
Other Operating Expenses, Total -602 -396 34 -185 1525
Operating Income 7012 3353 -16169 4162 3454
Interest Income (Expense), Net Non-Operating -2209 -1317 -976 -1052 -1239
Other, Net -133 10 -105 -257 -329
Net Income Before Taxes 4670 2046 -17250 2853 1886
Net Income After Taxes 4166 1022 -15561 2410 1390
Minority Interest -16 -22 -8 -19 -16
Net Income Before Extra. Items 4150 1000 -15569 2391 1374
Total Extraordinary Items 0 5074 1700 321
Net Income 4150 1000 -10495 4091 1695
Income Available to Common Excl. Extra. Items 4150 1000 -15569 2391 1374
Income Available to Common Incl. Extra. Items 4150 1000 -10495 4091 1695
Diluted Net Income 4150 1000 -10495 4091 1695
Diluted Weighted Average Shares 982.42 982.42 982.42 981.69 940.76
Diluted EPS Excluding Extraordinary Items 4.22426 1.01789 -15.8476 2.4356 1.46052
Dividends per Share - Common Stock Primary Issue 2.4 2 2 2.8 2.8
Diluted Normalized EPS 8.12248 4.39197 -1.24738 3.32619 3.46921
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 14389 12000 11281 12819 14639
Revenue 14389 12000 11281 12819 14639
Cost of Revenue, Total 5733 4768 4247 5680 5176
Gross Profit 8656 7232 7034 7139 9463
Total Operating Expense 11416 10568 10082 12650 10427
Selling/General/Admin. Expenses, Total 4052 4426 4079 4472 3945
Research & Development 1571 1614 1576 1928 1454
Other Operating Expenses, Total 60 -240 180 570 -148
Operating Income 2973 1432 1199 169 4212
Interest Income (Expense), Net Non-Operating -367 -562 -598 -692 -490
Net Income Before Taxes 2606 870 601 -523 3722
Net Income After Taxes 2182 609 552 -289 3294
Minority Interest -4 2 -6 -9 -3
Net Income Before Extra. Items 2178 611 546 -298 3291
Total Extraordinary Items
Net Income 2178 611 546 -298 3291
Income Available to Common Excl. Extra. Items 2178 611 546 -298 3291
Income Available to Common Incl. Extra. Items 2178 611 546 -298 3291
Diluted Net Income 2178 611 546 -298 3291
Diluted Weighted Average Shares 982.42 982.42 982.42 982.42 982.388
Diluted EPS Excluding Extraordinary Items 2.21697 0.62193 0.55577 -0.30333 3.35
Dividends per Share - Common Stock Primary Issue 0 2.4 0 0 0
Diluted Normalized EPS 2.58431 2.40752 0.69881 1.09337 3.31397
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 37760 32578 35675 32439 31065
Cash and Short Term Investments 10153 7739 11883 5404 5002
Cash & Equivalents 5171 4564 4191 3185 4052
Short Term Investments 4982 3175 7692 2219 950
Total Receivables, Net 13450 12980 12157 14851 14137
Accounts Receivable - Trade, Net 10312 10047 9552 11678 11714
Total Inventory 13636 11314 10961 10650 11132
Prepaid Expenses 297 307 314 290 344
Other Current Assets, Total 224 238 360 1244 450
Total Assets 124877 120241 116804 126174 126732
Property/Plant/Equipment, Total - Net 13674 12688 11723 12479 12943
Property/Plant/Equipment, Total - Gross 28337 26188 23646 24380 25458
Accumulated Depreciation, Total -14663 -13500 -11923 -11901 -12515
Goodwill, Net 39648 40106 36418 39126 38442
Intangibles, Net 24183 26258 25424 34709 36696
Long Term Investments 1486 1195 993 971 1586
Note Receivable - Long Term 1808 2005 1506 1501 1500
Other Long Term Assets, Total 6318 5411 5065 4949 4500
Total Current Liabilities 35084 29403 36768 23215 23125
Accounts Payable 7545 6792 5678 6426 6038
Accrued Expenses 434 339 374 343 367
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7539 3053 8359 1975 2958
Other Current Liabilities, Total 19566 19219 22357 14471 13762
Total Liabilities 86104 87221 86281 78921 80755
Total Long Term Debt 33781 36478 33198 36907 37708
Long Term Debt 32829 35549 32267 35955 37359
Capital Lease Obligations 952 929 931 952 349
Deferred Income Tax 727 931 1175 3755 4667
Minority Interest 153 148 152 180 171
Other Liabilities, Total 16359 20261 14988 14864 15084
Total Equity 38773 33020 30523 47253 45977
Common Stock 2515 2515 2515 2515 2387
Additional Paid-In Capital 18261 18261 18261 18261 18388
Retained Earnings (Accumulated Deficit) 17233 13345 13059 26151 25739
Total Liabilities & Shareholders’ Equity 124877 120241 116804 126174 126732
Total Common Shares Outstanding 982.424 982.424 982.424 982.424 932.552
Unrealized Gain (Loss) 112 212 117 310 122
Other Equity, Total 652 -1313 -3429 16 -659
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 39623 37760 38412 39550 38246
Cash and Short Term Investments 7975 10379 9074 8194 8194
Cash & Equivalents 4854 5171 4361 3412 5785
Short Term Investments 3121 5208 4713 4782 2409
Total Receivables, Net 18114 13742 14747 18385 17824
Accounts Receivable - Trade, Net 14559 10312 11000 14785 14601
Total Inventory 13531 13636 12791 11371 10869
Other Current Assets, Total 3 3 1800 1600 1359
Total Assets 125052 124877 131010 128794 125782
Property/Plant/Equipment, Total - Net 13312 13674 13921 13275 12786
Goodwill, Net 39254 39648 43452 41583 39789
Intangibles, Net 23352 24183 25997 25367 26066
Long Term Investments 2806 2942 2937 2792 2677
Note Receivable - Long Term 1188 1065 1130 1155 1323
Other Long Term Assets, Total 5517 5605 5161 5072 4895
Total Current Liabilities 34391 35084 33172 33643 31019
Accounts Payable 6268 7545 6549 6097 5847
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 9728 7861 5331 6573 5899
Other Current Liabilities, Total 18395 19678 21292 20973 19273
Total Liabilities 84188 86104 89738 90775 88345
Total Long Term Debt 33571 33791 39460 38061 36648
Long Term Debt 33571 33791 39460 38061 36648
Deferred Income Tax 714 727 657 836 926
Minority Interest 153 153 195 185 170
Other Liabilities, Total 15359 16349 16254 18050 19582
Total Equity 40864 38773 41272 38019 37437
Common Stock 2515 2515 2515 2515 2515
Additional Paid-In Capital 18261 18261 18261 18261 18261
Retained Earnings (Accumulated Deficit) 20088 17997 20496 17243 16661
Total Liabilities & Shareholders’ Equity 125052 124877 131010 128794 125782
Total Common Shares Outstanding 982.424 982.424 982.424 982.424 982.424
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 4166 1022 -15561 2430 1390
Cash From Operating Activities 7096 5128 4896 8187 7918
Cash From Operating Activities 6503 3056 13259 5365 6241
Non-Cash Items 521 795 1198 899 -2580
Cash Taxes Paid 2034 2159 1063 2561 2028
Cash Interest Paid 1296 1227 1301 1517 1331
Changes in Working Capital -4094 255 6000 -507 2867
Cash From Investing Activities -2381 855 -4073 -671 -34152
Capital Expenditures -2949 -2611 -2418 -2650 -2593
Other Investing Cash Flow Items, Total 568 3466 -1655 1979 -31559
Cash From Financing Activities -4220 -5645 423 -8389 23432
Financing Cash Flow Items -1251 -1200 -1276 -1478 -966
Total Cash Dividends Paid -1985 -1993 -2768 -2615 -2407
Issuance (Retirement) of Stock, Net -10 0 8986
Issuance (Retirement) of Debt, Net -974 -2452 4467 -4296 17819
Foreign Exchange Effects 112 35 -240 6 -581
Net Change in Cash 607 373 1006 -867 -3383
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2182 4166 3557 3005 3294
Cash From Operating Activities -3550 7096 4035 1381 -723
Cash From Operating Activities 1345 6503 4659 3562 1080
Non-Cash Items 237 521 1195 696 376
Cash Taxes Paid 531 2034 1342 968 442
Cash Interest Paid 183 1296 869 614 173
Changes in Working Capital -7314 -4094 -5376 -5882 -5473
Cash From Investing Activities 1602 -2381 -2448 -2029 742
Capital Expenditures -466 -2949 -1625 -899 -349
Other Investing Cash Flow Items, Total 2068 568 -823 -1130 1091
Cash From Financing Activities 1662 -4220 -2079 -739 1075
Financing Cash Flow Items -183 -1251 -828 -573 -137
Issuance (Retirement) of Debt, Net 1845 -974 704 1785 1197
Foreign Exchange Effects -31 112 293 238 132
Net Change in Cash -317 607 -199 -1149 1226
Total Cash Dividends Paid -1985 -1970 -1966
Issuance (Retirement) of Stock, Net 0 -10 15 15 15
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 3.1473 30920064 1392186 2023-04-11 LOW
MFS Investment Management Investment Advisor/Hedge Fund 3.0361 29826993 463404 2022-07-05 LOW
Harris Associates L.P. Investment Advisor/Hedge Fund 2.986 29334705 -298339 2022-03-28 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.9158 28645487 222488 2023-04-30 LOW
Capital Research Global Investors Investment Advisor 1.9514 19171366 21003 2023-04-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.8817 18486575 77399 2023-04-30 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.605 15767971 -25042 2023-04-30 LOW
Dodge & Cox Investment Advisor/Hedge Fund 1.5086 14821176 -6700 2023-03-31 LOW
Union Investment Privatfonds GmbH Investment Advisor 1.13 11101531 0 2022-12-31 LOW
Nuveen LLC Pension Fund 1.029 10109496 107466 2023-03-31 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.9203 9040807 153707 2023-04-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.849 8340523 -223114 2023-03-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.8276 8130854 -85800 2023-04-30 LOW
Invesco Advisers, Inc. Investment Advisor 0.8127 7983823 -151 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6831 6710712 42 2023-04-30 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.6592 6476031 -4316765 2023-04-30 MED
Deka Investment GmbH Investment Advisor/Hedge Fund 0.6428 6314632 -21437 2023-04-30 LOW
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.5714 5613177 -73568 2023-03-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.5634 5534693 90966 2023-04-30 LOW
Goldman Sachs Asset Management, L.P. Investment Advisor 0.5548 5450773 -76579 2022-12-19 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

530K+

Traders

87K+

Active clients monthly

$46M+

Monthly investing volume

$31M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Bayer Company profile

Browse our live chart to get all the information you need on the Bayer share price today.

Bayer AG (BAYN) is a multinational pharmaceutical and life sciences company. Comprising over 350 companies, it operates as one of the world's largest chemical manufacturers. The business is producing and marketing innovative products in four core segments: human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products.

The company is headquartered in Leverkusen, Germany, and has operations in nearly every country in the world with a majority of its business in Europe, North America and the Far East. At the end of 2019, Bayer had a team of over 100,000 employees working worldwide. The firm is among industry leaders in research and development, spending nearly 12 per cent of its revenues on this segment.

The business is included in the Fortune Global 500 list of the world’s largest companies.

Bayer shares are listed on the Frankfurt Stock Exchange under the ticker symbol BAYN. The company is a constituent of the Euro Stoxx 50 Index and the DAX 30 Index.

Follow the ups and downs of the Bayer share price in euro with Capital.com to spot the best trading opportunities.

Founded in 1863, Bayer was part of chemicals giant IG Farben in 1925-52, and then returned to being an independent company. The new millennium saw the landmark acquisition of Schering in 2006 – the largest takeover in Bayer's history, and one of the biggest pharma mergers of all time. In September 2015, the company spun out its materials science division into a separate publicly-traded firm Covestro (1COV), retaining about a 70 per cent interest in the business.

On its website, Bayer explains that its innovative products are contributing to finding solutions to some of the world’s major challenges. The company says it is improving quality of life for a growing population by focusing its R&D on preventing, alleviating and treating diseases. It is also helping to provide a reliable supply of food, feed and plant-based raw materials.

In fact, this 150-year-old company was the first in the world to introduce the flagship healthcare product aspirin. Today, the firm manufactures products that include anti-infectives, antibiotics, oncology, cardiovascular, central nervous system drugs, over-the-counter medications, diagnostics and animal-health products, as well as crop protection products, plastics and polyurethanes.

With Capital.com’s Bayer stock chart you can not only quickly view the current Bayer share price, but also trace the company’s shares value in historic terms. 

Bayer AG stock saw a period of almost uninterrupted growth from June 2012, when it traded at €46.87 per share, to April 2015, when it peaked at €143.88 per share. The stock then fell back to €82.79 per share in May 2016, right before recovering to hit €121.9 per share in 2017. 

However, the uplift was short-lived, and BAYN stock soon started to lose in value sharply, falling as low as €52.21 per share by June 14, 2019. The share price then retraced some of its losses to end the year at €72.81. On March 23, 2020, the stock closed the trading day at its multi-year lowest of €47.5 per share amid the broader market sell off caused by the Covid-19 pandemic outbreak and consequent economic uncertainty. 

Only a month later, in June 2020, BAYN shares were already hovering around the €70 level. Ever since, the Bayer stock price has experienced lots of volatility, characterised by multiple price fluctuations.

Stay up-to-date with the latest market news and watch the Bayer stock quote live at Capital.com.

Industry: Pharmaceuticals (NEC)

Kaiser-Wilhelm-Allee 1
LEVERKUSEN
NORDRHEIN-WESTFALEN 51373
DE

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

69.39 Price
-4.980% 1D Chg, %
Long position overnight fee -0.0155%
Short position overnight fee -0.0064%
Overnight fee time 21:00 (UTC)
Spread 0.03

US100

14,351.30 Price
-0.060% 1D Chg, %
Long position overnight fee -0.0255%
Short position overnight fee 0.0032%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

27,672.85 Price
+0.060% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

XRP/USD

0.52 Price
+6.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00406

Still looking for a broker you can trust?

Join the 530.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading